02:46 PM EST, 11/21/2025 (MT Newswires) -- AstraZeneca ( AZN ) said Friday the company plans a $2 billion investment to expand its manufacturing footprint in Maryland as part of its $50 billion investment roadmap.

The investment will be used to expand the company's biologics manufacturing facility in Frederick, build a new facility in Gaithersburg, and expected to support 2,600 jobs across the sites, the company said.

The expansion of the Frederick facility will almost double commercial manufacturing capacity. Facilities at both sites are expected to be operational by 2029, according to a statement.

Price: 91.79, Change: +3.11, Percent Change: +3.51